Sign in to continue:
Type a stock name or symbol, then select from the suggestions.
Posted on September 14, 2025 at 1:29 pm (GMT+8)
Company: Dahon Technology Co., Ltd. (大行科技有限公司)
Stock Code: 2543 (Main Board, HKEX)
Offer Shares: 62,240,000 H Shares
Hong Kong Public Offering: 6,224,000 H Shares
International Offering: 56,016,000 H Shares
Offer Price: HK$11.20 per H Share
Nominal Value: RMB 1.00 per H Share
Listing Date: Expected September 17, 2025
Application Method: White Form eIPO / CCASS EIPO / CCASS Investor Participant
Board Lot: 500 H Shares (minimum subscription HK$5,656.50 including fees)
Public Offering Opens: Sept 8, 2025, 9:00 a.m.
Application Deadline: Sept 11, 2025, 11:30 a.m.
Application Lists Close: Sept 11, 2025, 12:00 noon
Results of Allotment Announced: Sept 16, 2025
Refunds Dispatched: Sept 16, 2025
Dealings Commence: Sept 17, 2025, 9:00 a.m.
Founded: 1982, headquartered in Shenzhen, China
Core Business: R&D, manufacturing, and sales of folding bicycles, e-bikes, and mobility solutions
Brand: “DAHON” — globally recognized leader in folding bicycles
Sales Footprint: Over 40 countries across North America, Europe, and Asia
Market Position:
#1 in folding bicycle sales globally (2024, Frost & Sullivan)
18% market share in folding bicycles worldwide (2024)
25% market share in China (2024)
Folding Bicycles: Flagship category — compact, lightweight, urban-focused
E-bikes (electric): Expanding product line with rapid growth in China and Europe
Components & Accessories: Patented hinge systems, frames, and branded parts
IP Portfolio: Over 500 patents globally (structural folding designs, e-mobility tech)
Revenue:
2022: RMB 1,056.2m
2023: RMB 1,329.5m (+25.9%)
2024: RMB 1,602.7m (+20.5%)
Gross Profit Margin:
2022: 32.4%
2023: 34.8%
2024: 36.5%
Net Profit:
2022: RMB 87.3m
2023: RMB 118.6m
2024: RMB 159.2m
Net Margin: Improved from 8.3% (2022) to 9.9% (2024)
Cash & Equivalents (end-2024): RMB 452.6m
Total Assets (end-2024): RMB 1,984.3m
Total Liabilities (end-2024): RMB 876.1m
NAV per Share: HK$4.72 (pro forma post-IPO)
~35%: Expand manufacturing facilities in Shenzhen & Vietnam
~25%: R&D for new e-bike technologies and lightweight frames
~20%: Sales channel expansion (Europe & North America)
~10%: Marketing & branding
~10%: Working capital and general corporate purposes
Global Folding Bike Market:
2024 size: US$2.3B → expected US$4.5B by 2030
CAGR: 11.6%
China Folding Bike Market:
2024 size: RMB 5.6B → expected RMB 11.2B by 2030
CAGR: 12.0%
E-bike Market Growth:
Global CAGR: 10.8% (2024–2030)
China CAGR: 14.3% (2024–2030)
Heavy reliance on brand reputation and patent protection
Increasing global competition from European and Japanese e-bike makers
Raw material cost volatility (aluminum, lithium batteries)
Exposure to international trade tariffs and shipping costs
rrency fluctuations given large overseas sales share
Fill the bold blanks using Dahon’s latest audited/TTM numbers (prospectus “Financial Information” section) and HKEX quote at IPO price.
How to compute the cells (use IPO price and latest financials):
P/E (ttm) = IPO price ÷ EPS(ttm).
P/B = IPO price ÷ BVPS (book value per share, latest).
P/S = Market cap at IPO ÷ Revenue (ttm).
ROE = Net income (ttm) ÷ Average equity (ttm).
Net cash/(debt) = Cash & equivalents − total debt (latest).
Use prospectus tables for Dahon; use latest annual/ttm reports for peers.
Hesai Group (2525) — dual-list LiDAR supplier; debut mid-Sept.
GenFleet Therapeutics-B (2595) — biotech; debut that same week.
Dahon Technology (2543) — this IPO; scheduled mid-Sept.
Read-through: A busy calendar with recognisable brands can help day-one attention if overall risk sentiment is steady. Consumer/tech names clustering the same week tends to be supportive.
Wall Street Braces for Nvidia as Tech Weakness Drags Markets Lower US:DGT:Dow Jones Industrial Average SGX:S27.SI:S&P 500 US:QQQ:Nasdaq Composite US:BTC:Bitcoin U.S. stock futures were mostly unchanged Tuesday night as major indexes extended their losing...
Insilico IPO Analysis: Deep Dive into AI-Driven Drug Discovery Offering Insilico Prospectus Date: December 18, 2025 Insilico’s Hong Kong IPO: AI Drug Discovery Leader Targets Major Expansion in Landmark Offering IPO Snapshot: Key Terms...
AI Noon Brief: Hong Kong Tech Slumps, Crypto-Themed ETFs Pop, and Big Banks Recalibrate China Calls HK:07311.HK:XI2CSOPCOIN Crypto-linked ETF led midday gainers, closing at HK$7.45, up 12.0%. HK:09311.HK:XI2CSOPCOIN-U USD counter advanced to US$0.949, up...